Fragment-Based Drug Discovery 2012

Finding Fragments by various screening methods has become an established practice. Each of the technologies used have a different set of advantages and disadvantages. Questions such as how to select the most suitable projects, how and when to use screening methods such as crystallography, NMR, SPR or mass spec either as a standalone technique or in combination and how to correctly predict binding at active sites will be addressed in this meeting. In addition, new challenges are arising and will be discussed, such as fragment docking, fragment library design, ligand efficiency, fragment selecitivity and specificity.

Topics to be Covered in this Conference:

-Fragment-to-Lead Generation and Optimization

-Design Strategies

-Screening Technologies

-Computational approaches

-Success Stories

-Emerging Technologies

-Fragment Binding / Linking / Diversity

-Fragment Libraries

-Labeling

-NMR screening for ligand detection

-Crystallography based fragment screening

-SPR Technology

-Thermal shift assays

-Mass Spec

-Case Studies and Success Stories

-"Hit" – Validation

-Novel Targets

-Fragment selectivity

-In silico Fragment Design